
|Slideshows|April 10, 2019
The Mounting Burden of Neurological Disease
Author(s)Leo Robert
A new analysis provides a comprehensive update on this significant, and growing, cause of disability and death.
Advertisement
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Newly Unveiled EPIC Trial Pins Myasthenia Gravis Medications Nipocalimab Against Efgartigimod for Efficacy
2
Efgartigimod Treatment for CIDP Leads to Increased Spending, Study Shows
3
Phase 3 MG0020 Trial Highlights Success of Self-Administered Rozanolixizumab for Generalized Myasthenia Gravis
4
Episode 153: Overviewing the 2025 Alzheimer's Association's Blood-Based Biomarker Guidelines
5






































